Schedule 13G ownership disclosure

BENITEC BIOPHARMA INC

Security class unavailable · CUSIP: 08205P100

Event date: 2021-04-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
395,084
Percent of class
8.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-046246
Form type
SC 13G
Filer
Benitec Biopharma Inc.
CIK
CIK 1808898
Filed
Apr 05, 2021
Reporting period
Apr 01, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub